Recent studies are beginning to elucidate how the alteration in expression and/or activity of Lck may result in pathological conditions like chronic lymphocytic leukemia (CLL) and other blood cancers [3]. The gene discussed is LCK; the disease is B-cell chronic lymphocytic leukemia.